Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Data Tables


Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PA k) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (351 K)



View HTML View PDF

Section XIII
13.1a Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1998 to 2007 Table 13.1a(55 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.1b Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 13.1b(55 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.2 Time to Transplant, 1998 to 2007 New Heart-Lung Waiting List Registrations Table 13.2(96 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
13.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Heart-Lung Waiting List Table 13.3(62 k)
Age
Blood Type
Diagnosis
Gender
Race
13.4 Transplant Recipient Characteristics, 1998 to 2007 Heart-Lung Recipients Table 13.4(56 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
13.5 Incidence of Transplant, 1998 to 2007 Heart-Lung Transplants per 1 Million Population Table 13.5(140 k)
13.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6a(36 k)
13.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Heart-Lung Transplants Table 13.6b(37 k)
13.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Heart-Lung Transplants Table 13.6c(37 k)
13.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6d(36 k)
13.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6e(38 k)
13.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6f(38 k)
13.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6g(51 k)
13.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Heart-Lung Transplants Table 13.6h(102 k)
13.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6i(63 k)
13.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Heart-Lung Transplantation Table 13.7(116 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
13.8 Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.8(49 k)
Age
Gender
Race
Diagnosis
State of Center
13.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.9(30 k)
13.10 Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.10(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.11(30 k)
13.12 Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.12(49 k)
Age
Gender
Race
Diagnosis
State of Center
13.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.13(30 k)
13.14 Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.14(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.15(30 k)
13.16 Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1998 to 2006 Table 13.16(54 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
13.17 Transplants by State and Transplant Center, 1998 to 2007 Heart-Lung Table 13.17(138 k)